Clinical Trial Update: Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating human umbilical cord-derived mesenchymal stem cells for decompensated cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis

Drugs mentioned

• Human Umbilical Cord-derived Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Decompensated Cirrhosis | Phase 2 | Status: UNKNOWN